Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic Trait. [PDF]
Liu C +21 more
europepmc +1 more source
Individualised doses of azathioprine (AZA) may be prescribed by monitoring the levels of the enzyme thiopurine methyltransferase (TPMT). The measurements of thiopurine metabolites of AZA, 6-thioguanine (6-TGN) and 6-methylmercaptopurine (6-MMP), have also been reported as new markers of AZA activity.To describe TPMT phenotype in our population and to ...
M, Alvarez Beltran +4 more
openaire +1 more source
Identification of cellular proteome using two-dimensional difference gel electrophoresis in ST cells infected with transmissible gastroenteritis coronavirus [PDF]
core +1 more source
Differential effects of thiopurine methyltransferase (TPMT) and multidrug resistance-associated protein gene 4 (MRP4) on mercaptopurine toxicity. [PDF]
Liu C +5 more
europepmc +1 more source
Integration of a standardized pharmacogenomic platform for clinical decision support at Boston Children's Hospital [PDF]
Brownstein, Catherine A. +7 more
core +1 more source
Frequency of thiopurine methyltransferase variants and exploratory predictors of azathioprine-induced leukopenia in Saudi patients with inflammatory bowel disease. [PDF]
Meeralam YK +7 more
europepmc +1 more source
Thiopurine methyltransferase genotype and activity cannot predict outcomes of azathioprine maintenance therapy for antineutrophil cytoplasmic antibody associated vasculitis: A retrospective cohort study. [PDF]
Hessels AC +3 more
europepmc +1 more source
Azathioprine (AZA) and 6-mercaptopurine (6MP) are used in the treatment of pediatric inflammatory bowel disease (IBD). Genetic variations in thiopurine S-methyltranfarase (TPMT) gene have been correlated with enzyme activity and with the occurrence of adverse events to AZA and 6MP.
Muaria, Gazouli +6 more
openaire +1 more source
Thiopurine methyltransferase and treatment outcome in the UK acute lymphoblastic leukaemia trial ALL2003. [PDF]
Lennard L +3 more
europepmc +1 more source

